Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

405.00

Mkt cap

93B

Volume

2.6M

High

408.58

P/E Ratio

14.58

52-wk high

567.26

Low

398.69

Div yield

0.02

52-wk low

397.98

Analysts have provided a range of ratings for Elevance Health (NYSE:ELV) over the past three months, with most being somewhat bullish. The average 12-month price target is $607.47, slightly down from previous estimates. Despite a slight revenue decline, Elevance Health shows strong financial performance with high net margins and ROE. However, it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a $600 price target.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 3:26 pm

Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round.' He recommended buying Applied Materials (AMAT) and expressed negative views on Snap (SNAP), Aflac (AFL), Albemarle (ALB), Elevance Health (ELV), and Main Street Capital (MAIN). He preferred Chubb (CB) over Aflac in the insurance sector and UnitedHealth Group (UNH) over Elevance Health. He also commented on Alibaba (ABBA) as an 'incredibly cheap stock.'

Portfolio Pulse from Avi Kapoor

August 13, 2024 | 12:50 pm

Elevance Health (NYSE:ELV) has significantly outperformed the market over the past 20 years, delivering an average annual return of 13.6%. A $1000 investment in ELV 20 years ago would be worth $12,859.72 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 07, 2024 | 8:30 pm

Elevance Health (NYSE:ELV) has significantly outperformed the market over the past 15 years, delivering an average annual return of 16.46%. A $1000 investment in ELV 15 years ago would be worth $10,002.13 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

July 25, 2024 | 6:00 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a $600 price target.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:07 pm

Wells Fargo analyst Stephen Baxter maintains an Overweight rating on Elevance Health (NYSE:ELV) but lowers the price target from $600 to $593.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 1:48 pm

TD Cowen analyst Ryan Langston maintains a Buy rating on Elevance Health (NYSE:ELV) but lowers the price target from $624 to $589.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 4:42 pm

BofA downgraded Elevance Health (ELV) due to Medicaid pressure and lower peer valuations. ELV's Q2 revenue was $43.2 billion, slightly above consensus but down 0.4% YoY. Medicaid attrition and higher premium yields were noted. BofA lowered ELV's price target from $646 to $530 and downgraded it to Neutral. Other analysts had mixed reactions.

Portfolio Pulse from Vandana Singh

July 18, 2024 | 6:50 pm

Financial giants have made a bearish move on Elevance Health (NYSE:ELV) with 87% of options trades being bearish. Significant options trades include 6 puts valued at $365,806 and 2 calls valued at $245,525. Analysts have mixed ratings with a consensus target price of $589.2.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 5:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.